[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3617 Introduced in Senate (IS)]
<DOC>
117th CONGRESS
2d Session
S. 3617
To amend the Office of National Drug Control Policy Reauthorization Act
of 2006 to modify the authority of the Office of National Drug Control
Policy and the United States Anti-Doping Agency, and for other
purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
February 9, 2022
Mrs. Blackburn introduced the following bill; which was read twice and
referred to the Committee on Commerce, Science, and Transportation
_______________________________________________________________________
A BILL
To amend the Office of National Drug Control Policy Reauthorization Act
of 2006 to modify the authority of the Office of National Drug Control
Policy and the United States Anti-Doping Agency, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Restoring Confidence to the World
Anti-Doping Agency Act of 2022''.
SEC. 2. AUTHORITY OF THE UNITED STATES ANTI-DOPING AGENCY WITH RESPECT
TO THE WORLD ANTI-DOPING AGENCY.
Section 701 of the Office of National Drug Control Policy
Reauthorization Act of 2006 (21 U.S.C. 2001) is amended--
(1) in subsection (a)--
(A) by amending paragraph (1) to read as follows:
``(1) United states olympic and paralympic committee.--The
term `United States Olympic and Paralympic Committee' means the
organization established by chapter 2205 of title 36, United
States Code.'';
(B) by redesignating paragraphs (1) and (3) as
paragraphs (4) and (1), respectively, and moving the
paragraphs so as to appear in numeric order; and
(C) by inserting after paragraph (2) the following:
``(3) Independent athlete.--The term `independent athlete'
means an amateur athlete who does not serve, in any capacity,
in--
``(A) the International Olympic Committee;
``(B) the International Paralympic Committee;
``(C) an international sports federation recognized
by the International Olympic Committee or the
International Paralympic Committee;
``(D) the United States Olympic and Paralympic
Committee; or
``(E) the World Anti-Doping Agency.'';
(2) in subsection (b)--
(A) by striking ``United States Olympic Committee''
each place it appears and inserting ``United States
Olympic and Paralympic Committee'';
(B) in paragraph (4), by striking the period at the
end and inserting ``; and''; and
(C) by adding at the end the following:
``(5) carry out responsibilities with respect to the World
Anti-Doping Agency, as described in subsection (c).''; and
(3) by adding at the end the following:
``(c) Authority With Respect to the World Anti-Doping Agency.--
``(1) In general.--The Office of National Drug Control
Policy, in conjunction with the United States Anti-Doping
Agency, shall--
``(A) use all available tools to ensure that--
``(i) the World Anti-Doping Agency
maintains a proper conflict-of-interest policy
that prohibits an individual from serving as a
member of the Executive Committee of the World
Anti-Doping Agency if, during the preceding 2-
year period, the individual served in any
capacity for a sports federation that is or was
under the jurisdiction of the World Anti-Doping
Agency; and
``(ii) independent athletes from the United
States and other democratic countries, or
representatives of such athletes, have voting
positions on the Executive Committee and
governing bodies of the World Anti-Doping
Agency, including the foundation board and all
standing committees and working groups;
``(B) demonstrate leadership within the global
community;
``(C) have strict standards that work toward
countering the state-sponsored doping system of the
Russian Federation and other state-sponsored, systemic
fraud through doping; and
``(D) work collaboratively with democratic
countries.
``(2) Determination.--
``(A) In general.--Not later than 90 days after the
date of the enactment of this subsection, the Office of
National Drug Control Policy, in conjunction with the
United States Anti-Doping Agency, shall make a
determination as to whether the World Anti-Doping
Agency--
``(i) has a credible and independent
governance model that provides for fair
representation of the United States;
``(ii) maintains a conflict-of-interest
policy described in paragraph (1)(A)(i); and
``(iii) allows independent athletes from
the United States and other democratic
countries, or representatives of such athletes,
to have voting positions on the Executive
Committee and governing bodies of the World
Anti-Doping Agency, including the foundation
board and all standing committees and working
groups.
``(B) Accountability.--In the case of a
determination under subparagraph (A) that the World
Anti-Doping Agency does not have such a governance
model, maintain such a conflict-of-interest policy, or
allow such voting positions, the Office of National
Drug Control Policy, in conjunction with the United
States Anti-Doping Agency, shall--
``(i) submit a request to the Government
Accountability Office to indicate the amount of
United States taxpayer dollars used to pay dues
to the World Anti-Doping Agency;
``(ii) demand that the United States have
fair representation in World Anti-Doping
Agency, including not fewer than one
representative on each of--
``(I) the Executive Committee of
the World Anti-Doping Agency; and
``(II) any other governing body of
the World Anti-Doping Agency for which
the United States pays dues; and
``(iii) issue a report that describes the
justifications, and the countries responsible,
for blocking the United States from the
Executive Committee of the World Anti-Doping
Agency.
``(3) United states participation in executive committee of
the world anti-doping agency.--
``(A) In general.--As a condition of United States
participation in the World Anti-Doping Agency--
``(i) the United States shall be allotted
not fewer than one seat on the Executive
Committee of the World Anti-Doping Agency for
as long as such Executive Committee is a
representative body as structured on the date
of the enactment of this subsection; and
``(ii) the World Anti-Doping Agency shall
make a legal commitment to the Office of
National Drug Control Policy and the United
States Anti-Doping Agency that states there
will be not fewer than one representative of
the United States on such Executive Committee
at all times.
``(B) Refund of dues.--If such Executive Committee
appoints not fewer than one representative of the
United States during the one-year period beginning on
the date of the enactment of this subsection, the
Office of National Drug Control Policy or the United
States Anti-Doping Agency may not appeal to the World
Anti-Doping Agency for a refund of dues paid during the
period in which the United States did not have a
representative on such Executive Committee.''.
<all>